Recipharm AB (RECI B)-Financial and Strategic SWOT Analysis Review

Recipharm AB (RECI B)-Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH133157FSA
  • |
  • Pages: 25
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Recipharm AB (Recipharm) a subsidiary of B&E Participation AB is a contract development and manufacturing organization that offers a wide range of services to pharmaceutical companies. The organization operates business in two reportable segments that include manufacturing, and development and technology. Its manufacturing segment provides contract manufacturing of pharmaceuticals in a wide range of forms including semi-solids, and oral liquids, solid dose, sterile products, besides clinical trial material including APIs and other drugs. Recipharm's Development & Technology segment offers services that include raw material supply, formulation development and development of validated analytical methods, and among others. The organization also operates in the UK, Germany, Spain, Italy, Sweden, France, and others. Recipharm is headquartered in Jordbro, Sweden.

Recipharm AB Key Recent Developments

Apr 27,2017: Recipharm: Interim report January-March 2017

Apr 24,2017: Recipharm opens new GMP suite for clinical trial material

Apr 21,2017: Recipharm delivers first serialised batch to Saudi Arabia

Apr 11,2017: Recipharm appoints Henrik Stenqvist as new Chief Financial Officer

Feb 23,2017: Recipharm: Full Year report January-December 2016

This comprehensive SWOT profile of Recipharm AB provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Recipharm AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Section 1-About the Company

Recipharm AB-Key Information

Recipharm AB-Overview

Recipharm AB-Key Employees

Recipharm AB-Key Employee Biographies

Recipharm AB-Key Operational Heads

Recipharm AB-Major Products and Services

Recipharm AB-History

Recipharm AB-Company Statement

Recipharm AB-Locations And Subsidiaries

Recipharm AB-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Recipharm AB-Business Description

Recipharm AB-Corporate Strategy

Recipharm AB-SWOT Analysis

SWOT Analysis-Overview

Recipharm AB-Strengths

Recipharm AB-Weaknesses

Recipharm AB-Opportunities

Recipharm AB-Threats

Recipharm AB-Key Competitors

Section 3-Company Financial Performance Charts

Recipharm AB-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix



Ratio Definitions

About GlobalData

Contact Us


Note*: Some sections may be missing if data is unavailable for the company

List of Figures

Recipharm AB, Performance Chart

Recipharm AB, Ratio Charts

List of Tables

Recipharm AB, Key Information

Recipharm AB, Key Ratios

Recipharm AB, Share Data

Recipharm AB, Major Products and Services

Recipharm AB, History

Recipharm AB, Key Employees

Recipharm AB, Key Employee Biographies

Recipharm AB, Key Operational Heads

Recipharm AB, Other Locations

Recipharm AB, Subsidiaries

Recipharm AB, Key Manufacturing facilities

Recipharm AB, Key Competitors

Recipharm AB, SWOT Analysis

Recipharm AB, Ratios based on current share price

Recipharm AB, Annual Ratios

Recipharm AB, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Recipharm AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 300 INR 20235
Site License
USD 600 INR 40470
Corporate User License
USD 900 INR 60705



Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]